Literature DB >> 21825236

Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease.

Carlos Cruchaga1, Petra Nowotny, John S K Kauwe, Perry G Ridge, Kevin Mayo, Sarah Bertelsen, Anthony Hinrichs, Anne M Fagan, David M Holtzman, John C Morris, Alison M Goate.   

Abstract

BACKGROUND: Apolipoprotein E (APOE) is the most statistically significant genetic risk factor for late-onset Alzheimer disease (LOAD). The linkage disequilibrium pattern around the APOE gene has made it difficult to determine whether all the association signal is derived from APOE or whether there is an independent signal from a nearby gene.
OBJECTIVE: To attempt to replicate a recently reported association of APOE 3-TOMM40 haplotypes with risk and age at onset.
DESIGN: We used standard techniques to genotype several polymorphisms in the APOE-TOMM40 region in a large case-control series, in a series with cerebrospinal fluid biomarker data, and in brain tissue.
SETTING: Alzheimer's Disease Research Center. PARTICIPANTS: Research volunteers who were cognitively normal or had Alzheimer disease. MAIN OUTCOME MEASURES: Disease status and age at onset.
RESULTS: We did not replicate the previously reported association of the polyT polymorphism (rs10524523) with risk and age at onset. We found a significant association between rs10524523 and risk of LOAD in APOE 33 homozygotes but in the opposite direction as the previously reported association (the very long allele was underrepresented in cases vs controls in this study (P = .004]). We found no association between rs10524523 and cerebrospinal fluid tau or β-amyloid 42 levels or TOMM40 or APOE gene expression.
CONCLUSIONS: Although we did not replicate the earlier association between the APOE 3-TOMM40 haplotypes and age at onset, we observed that the polyT polymorphism is associated with risk of LOAD in APOE 33 homozygotes in a large case-control series but in the opposite direction as in the previous study.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21825236      PMCID: PMC3204798          DOI: 10.1001/archneurol.2011.155

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  27 in total

1.  A comparison of bayesian methods for haplotype reconstruction from population genotype data.

Authors:  Matthew Stephens; Peter Donnelly
Journal:  Am J Hum Genet       Date:  2003-10-20       Impact factor: 11.025

2.  Fluorescence-based fragment size analysis.

Authors:  Peter Imle
Journal:  Methods Mol Biol       Date:  2005

3.  Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association.

Authors:  Chang-En Yu; Howard Seltman; Elaine R Peskind; Nichole Galloway; Peter X Zhou; Elisabeth Rosenthal; Ellen M Wijsman; Debby W Tsuang; Bernie Devlin; Gerard D Schellenberg
Journal:  Genomics       Date:  2007-04-16       Impact factor: 5.736

4.  Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

Authors:  Anne M Fagan; Mark A Mintun; Robert H Mach; Sang-Yoon Lee; Carmen S Dence; Aarti R Shah; Gina N LaRossa; Michael L Spinner; William E Klunk; Chester A Mathis; Steven T DeKosky; John C Morris; David M Holtzman
Journal:  Ann Neurol       Date:  2006-03       Impact factor: 10.422

5.  Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.

Authors:  Anne M Fagan; Catherine M Roe; Chengjie Xiong; Mark A Mintun; John C Morris; David M Holtzman
Journal:  Arch Neurol       Date:  2007-01-08

6.  Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.

Authors:  L Berg; D W McKeel; J P Miller; M Storandt; E H Rubin; J C Morris; J Baty; M Coats; J Norton; A M Goate; J L Price; M Gearing; S S Mirra; A M Saunders
Journal:  Arch Neurol       Date:  1998-03

7.  Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer's disease presenilin 1 mutation.

Authors:  John S K Kauwe; Sarah Jacquart; Sumi Chakraverty; Jun Wang; Kevin Mayo; Anne M Fagan; David M Holtzman; John C Morris; Alison M Goate
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

8.  Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes.

Authors:  Gyungah Jun; Adam C Naj; Gary W Beecham; Li-San Wang; Jacqueline Buros; Paul J Gallins; Joseph D Buxbaum; Nilufer Ertekin-Taner; M Daniele Fallin; Robert Friedland; Rivka Inzelberg; Patricia Kramer; Ekaterina Rogaeva; Peter St George-Hyslop; Laura B Cantwell; Beth A Dombroski; Andrew J Saykin; Eric M Reiman; David A Bennett; John C Morris; Kathryn L Lunetta; Eden R Martin; Thomas J Montine; Alison M Goate; Deborah Blacker; Debby W Tsuang; Duane Beekly; L Adrienne Cupples; Hakon Hakonarson; Walter Kukull; Tatiana M Foroud; Jonathan Haines; Richard Mayeux; Lindsay A Farrer; Margaret A Pericak-Vance; Gerard D Schellenberg
Journal:  Arch Neurol       Date:  2010-08-09

9.  Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants.

Authors:  Andrew Grupe; Richard Abraham; Yonghong Li; Charles Rowland; Paul Hollingworth; Angharad Morgan; Luke Jehu; Ricardo Segurado; David Stone; Eric Schadt; Maha Karnoub; Petra Nowotny; Kristina Tacey; Joseph Catanese; John Sninsky; Carol Brayne; David Rubinsztein; Michael Gill; Brian Lawlor; Simon Lovestone; Peter Holmans; Michael O'Donovan; John C Morris; Leon Thal; Alison Goate; Michael J Owen; Julie Williams
Journal:  Hum Mol Genet       Date:  2007-02-22       Impact factor: 6.150

10.  A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease.

Authors:  Keith D Coon; Amanda J Myers; David W Craig; Jennifer A Webster; John V Pearson; Diane Hu Lince; Victoria L Zismann; Thomas G Beach; Doris Leung; Leslie Bryden; Rebecca F Halperin; Lauren Marlowe; Mona Kaleem; Douglas G Walker; Rivka Ravid; Christopher B Heward; Joseph Rogers; Andreas Papassotiropoulos; Eric M Reiman; John Hardy; Dietrich A Stephan
Journal:  J Clin Psychiatry       Date:  2007-04       Impact factor: 4.384

View more
  64 in total

Review 1.  The genetics and neuropathology of Alzheimer's disease.

Authors:  Gerard D Schellenberg; Thomas J Montine
Journal:  Acta Neuropathol       Date:  2012-05-23       Impact factor: 17.088

Review 2.  The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives.

Authors:  Russell H Swerdlow; Jeffrey M Burns; Shaharyar M Khan
Journal:  Biochim Biophys Acta       Date:  2013-09-23

3.  Hippocampal thinning linked to longer TOMM40 poly-T variant lengths in the absence of the APOE ε4 variant.

Authors:  Alison C Burggren; Zanjbeel Mahmood; Theresa M Harrison; Prabha Siddarth; Karen J Miller; Gary W Small; David A Merrill; Susan Y Bookheimer
Journal:  Alzheimers Dement       Date:  2017-02-07       Impact factor: 21.566

Review 4.  Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy.

Authors:  Chia-Chen Liu; Chia-Chan Liu; Takahisa Kanekiyo; Huaxi Xu; Guojun Bu
Journal:  Nat Rev Neurol       Date:  2013-01-08       Impact factor: 42.937

5.  PTCD1 Is Required for Mitochondrial Oxidative-Phosphorylation: Possible Genetic Association with Alzheimer's Disease.

Authors:  Daniel Fleck; Lilian Phu; Erik Verschueren; Trent Hinkle; Mike Reichelt; Tushar Bhangale; Benjamin Haley; Yuanyuan Wang; Robert Graham; Donald S Kirkpatrick; Morgan Sheng; Baris Bingol
Journal:  J Neurosci       Date:  2019-04-04       Impact factor: 6.167

6.  The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes.

Authors:  Lior Greenbaum; Ramit Ravona Springer; Michael W Lutz; Anthony Heymann; Irit Lubitz; Itzik Cooper; Efrat Kravitz; Mary Sano; Allen D Roses; Jeremy M Silverman; Ann M Saunders; Michal Schnaider Beeri
Journal:  Eur Neuropsychopharmacol       Date:  2014-06-13       Impact factor: 4.600

7.  Novel susceptibility loci for Alzheimer's disease.

Authors:  Christiane Reitz
Journal:  Future Neurol       Date:  2015-12

8.  An APOE-independent cis-eSNP on chromosome 19q13.32 influences tau levels and late-onset Alzheimer's disease risk.

Authors:  Shuquan Rao; Mahdi Ghani; Zhiyun Guo; Yuetiva Deming; Kesheng Wang; Rebecca Sims; Canquan Mao; Yao Yao; Carlos Cruchaga; Dietrich A Stephan; Ekaterina Rogaeva
Journal:  Neurobiol Aging       Date:  2018-01-03       Impact factor: 4.673

9.  The cis-regulatory effect of an Alzheimer's disease-associated poly-T locus on expression of TOMM40 and apolipoprotein E genes.

Authors:  Colton Linnertz; Lauren Anderson; William Gottschalk; Donna Crenshaw; Michael W Lutz; Jawara Allen; Sunita Saith; Mirta Mihovilovic; James R Burke; Kathleen A Welsh-Bohmer; Allen D Roses; Ornit Chiba-Falek
Journal:  Alzheimers Dement       Date:  2014-01-15       Impact factor: 21.566

Review 10.  APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease.

Authors:  Andrew B Wolf; Richard J Caselli; Eric M Reiman; Jon Valla
Journal:  Neurobiol Aging       Date:  2012-11-16       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.